Biology Reference
In-Depth Information
Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B,
Fornace AJ Jr (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45
is defective in ataxia-telangiectasia. Cell 71:587-597
Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint
determinant following irradiation. Proc Natl Acad Sci USA 89:7491-7495
Kurz SK, Reddehase MJ (1999) Patchwork pattern of transcriptional reactivation in the lungs
indicates sequential checkpoints in the transition from murine cytomegalovirus latency to
recurrence. J Virol 73:8612-8622
Kurz SK, Rapp
, Steffens H-P, Grzimek NKA, Schmalz S, Reddehase MJ (1999) Focal tran-
scriptional activity of murine cytomegalovirus during latency in the lungs. J Virol
73:482-494
Lang D, Stamminger T (1994) Minor groove contacts are essential for an interaction of the human
cytomegalovirus IE2 protein with its DNA target. Nucleic Acids Res 22:3331-3338
Lang D, Gebert S, Arlt H, Stamminger T (1995) Functional interaction between the human
cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol
69:6030-6037
Lee G, Wu J, Luu P, Ghazal P, Flores O (1996) Inhibition of the association of RNA polymerase
II with the preinitiation complex by a viral transcriptional repressor. Proc Natl Acad Sci USA
93:2570-2575
Lee H, Ahn J (2004) The sumoylation of HCMV (Towne) IE2 is not required for viral
growth in cultured human fibroblast. 29th International Herpesvirus Workshop, Reno,
Nevada.
Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-331
Liu B, Hermiston TW, Stinski MF (1991) A cis-acting element in the major immediate early (IE)
promoter of human cytomegalovirus is required for negative regulation by IE2. J Virol
65:897-903
Louria-Hayon I, Grossman T, Sionov RV, Alsheich O, Pandolfi PP, Haupt Y (2003) The promyelocytic
leukemia protein protects p53 from Mdm2-mediated inhibition and degradation. J Biol Chem
278:33134-33141
Lu Μ, Shenk T (1996) Human cytomegalovirus infection inhibits cell cycle progression at multi-
ple points including the transition from G1 to S. J Virol 70:8850-8857
Lukac DM, Manuppello JR, Alwine JC (1994) Transcriptional activation by the human cytomega-
lovirus immediate-early proteins: requirements for simple promoter structures and interactions
with multiple components of the transcription complex. J Virol 68:5184-5193
Lukac DM, Harel NY, Tanese N, Alwine JC (1997) TAF-like functions of human cytomegalovirus
immediate-early proteins. J Virol 71:7227-7239
Macias MP, Stinski MF (1993) An in vitro system for human cytomegalovirus immediate early 2
protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to
the major immediate early promoter. Proc Natl Acad Sci USA 90:707-711
Macias MP, Huang L, Lashmit PE, Stinski MF (1996) Cellular and viral protein binding to a
cytomegalovirus promoter transcription initiation site: effects on transcription. J Virol
70:3628-3635
Malone CL, Vesole DH, Stinski MF (1990) Transactivation of a human cytomegalovirus early
promoter by gene products from the immediate-early gene IE2 and augmentation by IE1:
mutational analysis of the viral proteins. J Virol 64:1498-1506
Marchini A, Liu H, Ahu H (2001) Human cytomegalovirus with IE-2 (UL122) deleted fails to
express early lytic genes. J Virol 75:1870-1878
McElroy AK, Dwarakanath RS, Spector DH (2000) Dysregulation of cyclin E gene expression in
human cytomegalovirus-infected cells requires viral early gene expression and is associated
with changes in the Rb-related protein p130. J Virol 74:4192-4206
Meier JL, Stinski MF (1997) Effect of a modulator deletion on transcription of the human cytome-
galovirus major immediate-early genes in infected undifferentiated and differentiated cells.
J Virol 71:1246-1255
Μ
